A paper published in Nature Communications last week set out to understand the molecular mechanisms which cause neurological symptoms reported “in up to 30% of [Covid] cases.” Neurological symptoms such as memory loss, sensory confusion, severe headaches, and even stroke are thought to be produced by the virus infecting the central nervous system.

“The neurological effects of Covid-19 share similarities to neurodegenerative diseases in which the presence of cytotoxic aggregated amyloid protein or peptides is a common feature … We suggest that cytotoxic aggregates of SARS-CoV-2 proteins may trigger neurological symptoms in Covid-19.” the study authors wrote.

“This [study] is about the Open Reading Frames (ORFs) and NOT the spike protein,” Jessica Rose wrote in an article explaining the findings of the study, see below. However, she asks: are amyloidogenic peptides residing in the SARS-nCoV-2 spike protein and since the modified spike proteins, used in the Moderna and Pfizer injectable biological products, are derived from the SARS-nCoV-2 spike, do these proposed amyloidogenic properties carry over?

Set aside your beliefs about whether a “virus” by your definition exists or not and think about the implications. The key to understanding the significance of this study’s findings is to understand what amyloids are.

Amyloids are aggregates of proteins and the word “amyloidogenic” means producing or tending to produce amyloid deposits. A 2014 article titled ‘When amyloids become prions’ noted all amyloids could be considered prions – from those involved in cell-to-cell transmission to those responsible for real neuronal invasion. A 2008 article titled ‘Amyloid fibrils’, aiming to highlight the key scientific findings and discuss how the stability of amyloid fibrils impacts bionanotechnology, concluded:

“Amyloid refers to the abnormal fibrous, extracellular, proteinaceous deposits found in organs and tissues … Amyloid fibrils are extremely strong, highly ordered and organised fibres that can be formed by a large number of proteins and peptides. Their stability and insolubility mean that they are useful in a large number of naturally occurring forms as well as bionanotechnology. However, it also means that they are destructive and have the ability to accumulate in the tissues in disease.”
Amyloid fibrils, Prion, 25 November 2008

We wonder if amyloidogenic peptide “vaccines” could provide insight into the extraordinary fibrous “clots” or biostructures being found by embalmers post-Covid injection, as being investigated by Dr. Jane Ruby and Mike Adams, see HERE and HERE. Could it be related? We don’t know and will have to wait and see what evidence further investigation provides.

Further reading: Bacteria’s amyloids display surprising structure, Science News, 23 February 2017

Below is Jessica Rose’s article, ‘An incredible paper was just published’ explaining the findings of the paper published last week in Nature Communications.

Telegram Channel

https://t.me/+LtveYCKl-JtlNzkx